2094O SKYSCRAPER-07: A phase III, randomised study of atezolizumab (atezo) with or without tiragolumab (tira) in patients (pts) with unresectable esophageal squamous cell carcinoma (ESCC) that has not progressed following definitive concurrent chemoradiotherapy (dCRT)

Ian Chau, B.C. Cho, M-H. Chen, Kenji Muro, Lucjan Wyrwicz, Bo Li, Shuang Gao, C-H. Hsu, Anthony Turpin, F. Lordick, Edward Cha, Qiong Wu, Suzy Kim, Jinquan Cai, L. Zhang, Jiawen Fan, Li Wang, Karyn A. Goodman, Manish A. Shah, R-H. Xu